BTX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
BioTime, Inc.'s quarterly cash and cash equivalents declined from Jun. 2013 ($14.31 Mil) to Sep. 2013 ($6.72 Mil) and declined from Sep. 2013 ($6.72 Mil) to Dec. 2013 ($5.50 Mil).
BioTime, Inc.'s annual cash and cash equivalents declined from Dec. 2011 ($22.21 Mil) to Dec. 2012 ($4.35 Mil) but then increased from Dec. 2012 ($4.35 Mil) to Dec. 2013 ($5.50 Mil).
Cash and cash equivalents on banks book.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
BioTime, Inc. Annual Data
BioTime, Inc. Quarterly Data